A Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Iguratimod Alone or Iguratimod in Combination With Methotrexate Versus Methotrexate Alone in Patients With Rheumatoid Arthritis
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 25 Feb 2016
At a glance
- Drugs Iguratimod (Primary) ; Methotrexate (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Jiangsu Simcere Pharmaceutical
- 22 Feb 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 12 Nov 2015 Planned End Date changed from 1 Dec 2015 to 1 Jan 2017, as reported by ClinicalTrials.gov.
- 12 Nov 2015 Planned primary completion date changed from 1 Dec 2015 to 1 Nov 2016, as reported by ClinicalTrials.gov.